Tesamorelin is a synthetic peptide that works as a growth hormone-releasing hormone (GHRH) analogue
Subcutaneous B12 injections are given under the skin, typically in the abdomen or outer thigh
Primary-source citations have been verified against PubMed, PMC, DOI registries, and journal full-text where available
The peptide increases survival of enteric neurons, enhances enteric glial cell proliferation, and modulates enteric serotonin release
Glutathione can lower the oxidative stress that ages skin, even out tone, and help your skin hold onto collagen
A comprehensive review of clinical trials from 2021 highlights that once-weekly subcutaneous semaglutide (1 mg) consistently lowered HbAc by 1.5 to 1.8% over 30 to 56 weeks, outperforming other medications including sitagliptin, dulaglutide, and insulin glargine in the SUSTAIN series.33 Real-world data from 2023 further support these findings, showing an average HbA1c reduction of approximately 0.9% and a fasting blood glucose decrease of 26 mg/dL after six months of once-weekly semaglutide use.34 These results underscore semaglutides ability to offer meaningful improvements in glycemic control and metabolic health for patients with T2DM